CDC37 is oncogenic because it stabilizes the structures of mutated or overexpressed oncogenic kinases. Targeting this chaperone activity, on which many tumours depend, is therefore an attractive option for broad-based therapy.
- Phillip J. Gray Jr
- Thomas Prince
- Stuart K. Calderwood
